Cellosaurus ESS-1 (CVCL_1205)

Cell line name ESS-1
Synonyms ESS1; Endometrial Stromal Sarcoma-1
Accession CVCL_1205
Resource Identification Initiative To cite this cell line use: ESS-1 (RRID:CVCL_1205)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: MD Anderson Cell Lines Project.
Doubling time: 63 hours (PubMed=9663606); ~120 hours (DSMZ).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Disease Endometrioid stromal sarcoma (NCIt: C8973)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; DSMZ

Markers:
AmelogeninX
CSF1PO10,14
D13S3178,12
D16S53912,13
D5S81810,12
D7S8209,11
TH017,9
TPOX8
vWA16,17
Web pages http://tcpaportal.org/mclp/
Publications

PubMed=9663606; DOI=10.1002/(SICI)1097-0215(19980729)77:3<424::AID-IJC19>3.0.CO;2-7
Gunawan B., Braun S., Cortes M.J., Bergmann F., Karl C., Fuzesi L.
Characterization of a newly established endometrial stromal sarcoma cell line.
Int. J. Cancer 77:424-428(1998)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P., Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

Cross-references
Cell line collections DSMZ; ACC-461
Cell line databases/resources CCLE; ESS1_ENDOMETRIUM
Cosmic-CLP; 907000
GDSC; 907000
LINCS_LDP; LCL-1507
Lonza; 1422
Ontologies CLO; CLO_0002954
Biological sample resources BioSample; SAMN03473556
Chemistry resources ChEMBL-Cells; CHEMBL3308384
ChEMBL-Targets; CHEMBL1075444
Gene expression databases GEO; GSM887009
GEO; GSM888078
GEO; GSM1669778
Polymorphism and mutation databases Cosmic; 907000
Cosmic; 1105622
Cosmic; 1576456